Susanna Campesan

Susanna Campesan

Auto-generated profile, based on publicly available information

Susanna Campesan

Department of Genetics and Genome Biology University of Leicester, University Road Leicester UK

Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 November 2020 in PLOS Genetics
Verified
Journal Article
Open access
PDF file
Daniel MaddisonDaniel Maddison
Daniel Maddison
MAMónica Alfonso-Núñez
Mónica Alfonso-Núñez
ASAisha M. Swaih
Aisha M. Swaih
CBCarlo Breda
Carlo Breda
SCSusanna Campesan
Susanna Campesan
FGFlaviano Giorgini
Flaviano Giorgini
The enzyme kynurenine 3-monooxygenase (KMO) operates at a critical branch-point in the kynurenine pathway (KP), the major route of tryptophan metabolism. As the KP has been implicated in the pathogenesis of several human diseases, KMO and other enzymes that control metabolic flux through the pathway are potential therapeutic targets for these disorders. While KMO is localized to the outer mitochondrial membrane in eukaryotic organisms, no mitochondrial role for KMO has been described. In this study, KMO deficientDrosophila melanogasterwere investigated for mitochondrial phenotypesin vitroandin vivo. We find that a loss of function allele or RNAi knockdown of theDrosophilaKMO ortholog (cinnabar) causes a range of morphological and functional alterations to mitochondria, which are independent of changes to levels of KP metabolites. Notably,cinnabargenetically interacts with the Parkinson’s disease associated genesPink1andparkin, as well as the mitochondrial fission geneDrp1, implicating KMO in mitochondrial dynamics and mitophagy, mechanisms which govern the maintenance of a healthy mitochondrial network. Overexpression of human KMO in mammalian cells finds that KMO plays a role in the post-translational regulation of DRP1. These findings reveal a novel mitochondrial role for KMO, independent from its enzymatic role in the kynurenine pathway.

3 May 2021 in Movement Disorders
Verified
Journal Article
Open access
PDF file
DKDavid J. Koss
David J. Koss
SCSusanna Campesan
Susanna Campesan
FGFlaviano Giorgini
Flaviano Giorgini
Tiago OuteiroTiago Outeiro
Tiago Outeiro
Intracellular vesicular trafficking is essential for neuronal development, function, and homeostasis and serves to process, direct, and sort proteins, lipids, and other cargo throughout the cell. This intricate system of membrane trafficking between different compartments is tightly orchestrated by Ras analog in brain (RAB) GTPases and their effectors. Of the 66 members of the RAB family in humans, many have been implicated in neurodegenerative diseases and impairment of their functions contributes to cellular stress, protein aggregation, and death. Critically, RAB39B loss‐of‐function mutations are known to be associated with X‐linked intellectual disability and with rare early‐onset Parkinson's disease. Moreover, recent studies have highlighted altered RAB39B expression in idiopathic cases of several Lewy body diseases (LBDs). This review contextualizes the role of RAB proteins in LBDs and highlights the consequences of RAB39B impairment in terms of endosomal trafficking, neurite outgrowth, synaptic maturation, autophagy, as well as alpha‐synuclein homeostasis. Additionally, the potential for therapeutic intervention is examined via a discussion of the recent progress towards the development of specific RAB modulators. © 2021 The Authors. Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society

1 February 2001 in Genetics
Verified
Journal Article
Open access
Federica SandrelliFederica Sandrelli
Federica Sandrelli
SCSusanna Campesan
Susanna Campesan
MRMaria Giovanna Rossetto
Maria Giovanna Rossetto
Clara BennaClara Benna
Clara Benna
EZEmanuela Zieger
Emanuela Zieger
RCRodolfo Costa
Rodolfo Costa
The nonA gene of Drosophila melanogaster is important for normal vision, courtship song, and viability and lies ∼350 bp downstream of the dGpi1 gene. Full rescue of nonA mutant phenotypes can be achieved by transformation with a genomic clone that carries ∼2 kb of 5′ regulatory material and that encodes most of the coding sequence of dGpi1. We have analyzed this 5′ region by making a series of deleted fragments, fusing them to yeast GAL4 sequences, and driving UAS-nonA expression in a mutant nonA background. Regions that both silence and enhance developmental tissue-specific expression of nonA and that are necessary for generating optomotor visual responses are identified. Some of these overlap the dGpi1 sequences, revealing cis-regulation by neighboring gene sequences. The largest 5′ fragment was unable to rescue the normal electroretinogram (ERG) consistently, and no rescue at all was observed for the courtship song phenotype. We suggest that sequences within the nonA introns that were missing in the UAS-nonA cDNA may carry enhancer elements for these two phenotypes. Finally, we speculate on the striking observation that some of the cis-regulatory regions of nonA appear to be embedded within the coding regions of dGpi1.